Preventing muscle wasting by osteoporosis drug alendronatein vitroand in myopathy models via sirtuin-3 down-regulation-Reference-Cited by-同舟云学术

Preventing muscle wasting by osteoporosis drug alendronatein vitroand in myopathy models via sirtuin-3 down-regulation

Author:

Chiu Hsien-Chun¹,Chiu Chen-Yuan¹²,Yang Rong-Sen³,Chan Ding-Cheng⁴,Liu Shing-Hwa¹⁵⁶,Chiang Chih-Kang¹⁷

Affiliation:

1. Institute of Toxicology, College of Medicine; National Taiwan University; Taipei Taiwan

2. Institute of Food Safety and Health; College of Public Health, National Taiwan University; Taipei Taiwan

3. Departments of Orthopaedics, College of Medicine; National Taiwan University; Taipei Taiwan

4. Department of Geriatrics and Gerontology, College of Medicine; National Taiwan University; Taipei Taiwan

5. Department of Medical Research, China Medical University Hospital; China Medical University; Taichung Taiwan

6. Department of Pediatrics, College of Medicine; National Taiwan University; Taipei Taiwan

7. Department of Internal Medicine, College of Medicine; National Taiwan University; Taipei Taiwan

Funder

National Taiwan University Hospital

Ministry of Science and Technology, Taiwan

Publisher

Wiley

Subject

Physiology (medical),Orthopedics and Sports Medicine

Link

Reference65 articles.

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献